| Outcome Measures: |
Primary: Area under the ethinylestradiol plasma concentration time curve during a dosing interval (0 to 24 hours) at steady state (AUC0-24h,EE,SS), Measured in h\*pg/mL, From pre-dose to 24 hours after last dosing of oral contraceptive on day 8 and day 100|Area under the levonorgestrel plasma concentration time curve during a dosing interval (0 to 24 hours) at steady state (AUC0-24h,LN,SS), Measured in h\*pg/mL, From pre-dose to 24 hours after last dosing of oral contraceptive on day 8 and day 100 | Secondary: Maximum concentration of ethinylestradiol at steady state (Cmax,EE,SS), Measured in pg/mL, Within pre-dose to 24 hours after last dosing of oral contraceptive on day 8 and day 100|Maximum concentration of levonorgestrel at steady state (Cmax,LN,SS), Measured in pg/mL, Within pre-dose to 24 hours after last dosing of oral contraceptive on day 8 and day 100|Area under the paracetamol concentration-time curve for 0-60 minutes following a standardised meal (AUC0-60min,para), Measured in h\*μg/mL, From pre-dose to 60 minutes after dosing of paracetamol on day 1 and day 93|Area under the paracetamol concentration-time curve for 0-300 minutes following a standardised meal (AUC0-300min,para), Measured in h\*μg/mL, From pre-dose to 300 minutes after dosing of paracetamol on day 1 and day 93|Maximum observed paracetamol concentration following a standardised meal (Cmax,para), Measured in μg/mL, Within pre-dose to 300 minutes after dosing of paracetamol on day 1 and day 93
|
